Evolent Health Quarterly Balance Sheets Chart
Quarterly
|
Annual
Evolent Health Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2015-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | ||||||||||||||||||||||||||||||||||||||
| current assets: | ||||||||||||||||||||||||||||||||||||||
| cash and cash equivalents | 150,995,000 | 246,547,000 | 104,203,000 | 96,583,000 | 101,250,000 | 165,147,000 | 192,825,000 | 184,536,000 | 142,530,000 | 157,519,000 | 188,200,000 | 156,756,000 | 193,070,000 | 210,158,000 | 266,280,000 | 252,496,000 | 207,273,000 | 236,032,000 | 340,490,000 | 370,514,000 | 98,272,000 | 67,944,000 | 101,008,000 | 96,734,000 | 92,821,000 | 170,817,000 | 228,320,000 | 221,837,000 | 197,983,000 | 200,316,000 | 238,433,000 | 287,143,000 | 99,975,000 | 104,295,000 | 134,563,000 | 109,777,000 | 105,138,000 | 145,726,000 |
| restricted cash | 24,368,000 | 16,239,000 | 4,990,000 | 2,205,000 | 4,703,000 | |||||||||||||||||||||||||||||||||
| accounts receivable | 358,756,000 | 430,496,000 | 414,681,000 | 407,902,000 | 373,725,000 | 427,739,000 | 446,749,000 | 394,232,000 | 345,276,000 | 262,764,000 | 254,684,000 | 187,633,000 | 118,525,000 | 179,270,000 | 130,604,000 | 175,226,000 | 242,505,000 | 185,103,000 | 125,986,000 | 95,317,000 | 95,839,000 | 107,506,000 | 75,667,000 | 74,874,000 | 71,379,000 | 65,626,000 | 80,208,000 | 60,054,000 | 70,846,000 | 66,138,000 | 48,947,000 | 43,972,000 | 45,804,000 | 44,638,000 | 40,635,000 | 21,986,000 | 30,337,000 | 20,381,000 |
| prepaid expenses and other current assets | 28,138,000 | 34,652,000 | 28,938,000 | 23,183,000 | 25,943,000 | 24,766,000 | 30,331,000 | 36,822,000 | 41,416,000 | 33,757,000 | 20,678,000 | 24,328,000 | 37,173,000 | 34,313,000 | 51,391,000 | 33,965,000 | 38,032,000 | 33,696,000 | 61,034,000 | 55,381,000 | 30,473,000 | 25,449,000 | 28,488,000 | 29,749,000 | 32,810,000 | 30,495,000 | 22,618,000 | 14,667,000 | 15,757,000 | 17,369,000 | 8,404,000 | 16,144,000 | 12,556,000 | 11,667,000 | 11,011,000 | 4,983,000 | 5,300,000 | 4,208,000 |
| total current assets | 562,257,000 | 727,934,000 | 607,117,000 | 544,011,000 | 520,971,000 | 669,246,000 | 683,673,000 | 638,798,000 | 576,699,000 | 475,972,000 | 478,054,000 | 393,774,000 | 423,145,000 | 463,388,000 | 523,960,000 | 478,196,000 | 505,552,000 | 508,310,000 | 546,134,000 | 548,545,000 | 274,658,000 | 258,473,000 | 228,801,000 | 308,012,000 | 240,864,000 | 321,186,000 | 487,966,000 | 348,591,000 | 353,254,000 | 337,279,000 | 378,182,000 | 352,329,000 | 192,620,000 | 217,538,000 | 264,966,000 | 191,429,000 | 170,557,000 | 184,463,000 |
| investments and equity method investees | 8,978,000 | 8,569,000 | 8,588,000 | 8,405,000 | 8,371,000 | 8,197,000 | ||||||||||||||||||||||||||||||||
| property and equipment | 77,273,000 | 74,440,000 | 73,151,000 | 73,941,000 | 75,297,000 | 76,044,000 | 78,194,000 | 79,902,000 | 83,524,000 | 88,606,000 | 87,874,000 | 94,645,000 | 92,627,000 | 82,877,000 | 81,365,000 | 81,574,000 | 82,996,000 | 84,439,000 | 86,240,000 | 88,072,000 | 88,555,000 | 85,808,000 | 85,155,000 | 83,164,000 | 80,217,000 | 77,379,000 | 73,628,000 | 68,692,000 | 64,630,000 | 60,430,000 | 50,922,000 | 46,930,000 | 40,194,000 | 35,459,000 | 31,179,000 | 21,123,000 | 18,468,000 | 12,796,000 |
| right-of-use assets - operating | 5,342,000 | 5,726,000 | 6,134,000 | 9,244,000 | 9,905,000 | 10,790,000 | 11,983,000 | 17,406,000 | 27,472,000 | 44,408,000 | 49,027,000 | 50,696,000 | 50,873,000 | 48,485,000 | 50,203,000 | 50,118,000 | 51,904,000 | 53,686,000 | 57,799,000 | 60,240,000 | 66,113,000 | 63,038,000 | 72,173,000 | 75,768,000 | 76,712,000 | 63,855,000 | ||||||||||||
| prepaid expenses and other noncurrent assets | 4,081,000 | 3,188,000 | 3,569,000 | 3,914,000 | 2,672,000 | 2,304,000 | 4,028,000 | 3,264,000 | 3,163,000 | 3,543,000 | 2,378,000 | 3,064,000 | 6,655,000 | 7,211,000 | 6,790,000 | 6,606,000 | 6,311,000 | 6,253,000 | 7,647,000 | 10,947,000 | 11,264,000 | 15,181,000 | ||||||||||||||||
| contract cost assets | 12,504,000 | 13,334,000 | 13,378,000 | 13,203,000 | 13,419,000 | 12,471,000 | 12,120,000 | 13,413,000 | 14,648,000 | 16,497,000 | 17,461,000 | 24,588,000 | 22,721,000 | 22,041,000 | 32,624,000 | 25,198,000 | 22,367,000 | 25,322,000 | 26,687,000 | 28,491,000 | 31,713,000 | 34,193,000 | 36,482,000 | 29,998,000 | 24,485,000 | 22,463,000 | 19,147,000 | 14,252,000 | 10,890,000 | 9,982,000 | ||||||||
| intangible assets | 651,169,000 | 667,881,000 | 680,156,000 | 696,779,000 | 711,290,000 | 731,345,000 | 752,009,000 | 777,668,000 | 801,923,000 | 825,857,000 | 442,784,000 | 451,398,000 | 264,846,000 | 272,213,000 | 279,784,000 | 245,069,000 | 252,045,000 | 259,420,000 | 268,072,000 | 275,492,000 | 282,913,000 | 291,627,000 | 308,459,000 | 317,200,000 | 326,586,000 | 336,231,000 | 335,036,000 | 230,806,000 | 236,819,000 | 242,863,000 | 241,261,000 | 249,492,000 | 254,460,000 | 254,166,000 | 258,923,000 | 162,789,000 | 165,442,000 | 163,152,000 |
| goodwill | 1,137,321,000 | 1,137,320,000 | 1,137,320,000 | 1,137,342,000 | 1,116,538,000 | 1,116,539,000 | 1,116,542,000 | 1,117,543,000 | 1,117,556,000 | 1,117,945,000 | 722,774,000 | 722,790,000 | 426,228,000 | 426,274,000 | 426,297,000 | 349,010,000 | 349,009,000 | 349,022,000 | 354,734,000 | 354,722,000 | 354,695,000 | 569,797,000 | 572,064,000 | 771,887,000 | 772,164,000 | 770,334,000 | 768,124,000 | 635,088,000 | 635,282,000 | 635,246,000 | 628,186,000 | 628,341,000 | 628,653,000 | 627,204,000 | 626,569,000 | 459,703,000 | 459,703,000 | 608,903,000 |
| total assets | 2,461,532,000 | 2,653,451,000 | 2,544,411,000 | 2,501,764,000 | 2,475,109,000 | 2,643,673,000 | 2,680,308,000 | 2,669,615,000 | 2,646,831,000 | 2,589,459,000 | 1,817,293,000 | 1,759,182,000 | 1,303,912,000 | 1,339,149,000 | 1,419,458,000 | 1,253,525,000 | 1,293,367,000 | 1,305,584,000 | 1,370,185,000 | 1,391,789,000 | 1,270,134,000 | 1,450,754,000 | 1,498,015,000 | 1,713,901,000 | 1,652,256,000 | 1,629,374,000 | 1,722,281,000 | 1,322,676,000 | 1,321,620,000 | 1,306,310,000 | 1,312,697,000 | 1,299,030,000 | 1,138,352,000 | 1,154,446,000 | 1,199,839,000 | 851,280,000 | 852,801,000 | 1,015,514,000 |
| liabilities, mezzanine equity and shareholders’ equity | ||||||||||||||||||||||||||||||||||||||
| liabilities | ||||||||||||||||||||||||||||||||||||||
| current liabilities: | ||||||||||||||||||||||||||||||||||||||
| accounts payable | 69,460,000 | 57,813,000 | 96,025,000 | 50,087,000 | 39,030,000 | 77,346,000 | 48,246,000 | 51,776,000 | 76,953,000 | 51,012,000 | 57,174,000 | 61,863,000 | 96,565,000 | 64,036,000 | 96,084,000 | 37,785,000 | 39,879,000 | 78,574,000 | 32,068,000 | 32,177,000 | 73,691,000 | 80,035,000 | 37,488,000 | 120,024,000 | 28,758,000 | 39,007,000 | 146,760,000 | 30,535,000 | 34,258,000 | 22,445,000 | 42,930,000 | 27,292,000 | 26,280,000 | 39,613,000 | 43,892,000 | 14,486,000 | 12,375,000 | 16,699,000 |
| accrued liabilities | 63,886,000 | 99,531,000 | 66,361,000 | 120,454,000 | 84,788,000 | 165,099,000 | 149,849,000 | 193,961,000 | 166,676,000 | 170,236,000 | 111,198,000 | 132,238,000 | 75,846,000 | 115,068,000 | 107,241,000 | 55,774,000 | 52,339,000 | 61,069,000 | 84,507,000 | 76,979,000 | 35,305,000 | 28,203,000 | 33,343,000 | 41,632,000 | 52,631,000 | 53,018,000 | 48,957,000 | 47,189,000 | 39,477,000 | 37,955,000 | 29,572,000 | 21,094,000 | 25,919,000 | 22,320,000 | 29,160,000 | 11,839,000 | 8,513,000 | 6,047,000 |
| operating lease liability - current | 24,208,000 | 35,187,000 | 26,717,000 | 6,220,000 | 6,133,000 | 12,696,000 | 9,738,000 | 12,966,000 | 6,218,000 | 4,608,000 | 7,122,000 | 7,053,000 | 6,389,000 | 6,445,000 | 7,069,000 | 6,730,000 | 7,265,000 | 7,539,000 | 7,357,000 | 7,438,000 | 7,474,000 | 5,785,000 | 6,269,000 | |||||||||||||||
| accrued compensation and employee benefits | 38,262,000 | 35,914,000 | 33,719,000 | 31,614,000 | 31,302,000 | 29,106,000 | 56,385,000 | 50,095,000 | 38,290,000 | 27,527,000 | 52,460,000 | 37,646,000 | 29,371,000 | 19,390,000 | 51,861,000 | 34,542,000 | 25,852,000 | 19,360,000 | 48,278,000 | 28,130,000 | 20,996,000 | 16,195,000 | 34,691,000 | 27,031,000 | 26,860,000 | 15,872,000 | 25,460,000 | 28,989,000 | 23,168,000 | 16,508,000 | 35,390,000 | 30,987,000 | 21,787,000 | 16,993,000 | 38,408,000 | 21,287,000 | 16,991,000 | 21,925,000 |
| deferred revenue | 2,333,000 | 5,017,000 | 2,507,000 | 2,621,000 | 4,558,000 | 6,136,000 | 5,976,000 | 5,763,000 | 6,950,000 | 7,069,000 | 5,758,000 | 7,524,000 | 8,711,000 | 13,288,000 | 11,944,000 | 13,785,000 | 13,173,000 | 13,367,000 | 14,327,000 | 12,459,000 | 13,247,000 | 17,023,000 | 19,828,000 | 22,701,000 | 26,923,000 | 22,320,000 | 20,584,000 | 22,360,000 | 29,818,000 | 33,328,000 | 24,807,000 | 26,094,000 | 27,774,000 | 25,513,000 | 20,481,000 | 17,717,000 | 18,848,000 | 14,835,000 |
| short-term debt | 172,119,000 | 171,793,000 | 171,467,000 | 991,000 | ||||||||||||||||||||||||||||||||||
| reserve for claims and performance - based arrangements | 187,251,000 | 333,842,000 | 318,705,000 | 312,687,000 | 317,563,000 | 368,639,000 | 404,048,000 | 299,742,000 | 245,811,000 | 197,197,000 | 199,730,000 | 135,698,000 | 125,960,000 | 164,238,000 | 171,294,000 | 191,878,000 | 238,105,000 | 207,993,000 | ||||||||||||||||||||
| total current liabilities | 557,519,000 | 739,097,000 | 715,501,000 | 523,683,000 | 483,374,000 | 659,022,000 | 674,242,000 | 615,294,000 | 540,898,000 | 457,649,000 | 433,442,000 | 382,022,000 | 342,842,000 | 382,465,000 | 445,493,000 | 367,198,000 | 403,268,000 | 414,508,000 | 401,779,000 | 365,496,000 | 245,122,000 | 236,251,000 | 192,769,000 | 259,851,000 | 172,873,000 | 163,675,000 | 269,356,000 | 139,411,000 | 136,187,000 | 116,935,000 | 132,699,000 | 105,467,000 | 101,760,000 | 104,439,000 | 131,941,000 | 65,329,000 | 56,727,000 | 59,506,000 |
| long-term debt | 648,455,000 | 647,532,000 | 490,520,000 | 599,668,000 | 598,784,000 | 597,901,000 | 597,049,000 | 599,947,000 | 633,013,000 | 632,277,000 | 412,986,000 | 412,444,000 | 283,138,000 | 282,598,000 | ||||||||||||||||||||||||
| other long-term liabilities | 3,787,000 | 3,269,000 | 2,984,000 | 3,247,000 | 3,431,000 | 3,568,000 | 3,637,000 | 3,978,000 | 4,273,000 | 4,473,000 | 4,744,000 | 4,260,000 | 4,619,000 | 4,999,000 | 5,531,000 | 9,474,000 | 9,784,000 | 10,269,000 | 22,209,000 | 20,207,000 | 10,101,000 | 7,664,000 | 11,732,000 | 6,553,000 | 10,423,000 | 10,490,000 | 17,090,000 | 10,885,000 | 10,666,000 | 11,368,000 | 9,861,000 | 9,982,000 | 10,024,000 | 14,091,000 | 14,655,000 | 7,997,000 | 7,972,000 | 111,000 |
| tax receivables agreement liability | 108,105,000 | 108,105,000 | 108,105,000 | 108,105,000 | 108,105,000 | 108,105,000 | 107,932,000 | 112,134,000 | ||||||||||||||||||||||||||||||
| operating lease liabilities - noncurrent | 8,411,000 | 15,585,000 | 24,969,000 | 29,318,000 | 30,789,000 | 32,469,000 | 38,009,000 | 39,650,000 | 56,576,000 | 54,274,000 | 56,010,000 | 57,840,000 | 58,581,000 | 56,354,000 | 57,722,000 | 57,283,000 | 58,618,000 | 60,292,000 | 62,526,000 | 64,738,000 | 66,975,000 | 60,961,000 | 68,858,000 | 70,560,000 | 70,796,000 | 57,197,000 | ||||||||||||
| deferred tax liabilities | 10,450,000 | 11,114,000 | 10,900,000 | 11,892,000 | 12,559,000 | 13,378,000 | 13,311,000 | 26,913,000 | 33,889,000 | 36,284,000 | 4,744,000 | 3,608,000 | 1,644,000 | 1,524,000 | 1,403,000 | 1,023,000 | 957,000 | 1,085,000 | 728,000 | 1,390,000 | 1,326,000 | 2,130,000 | 1,942,000 | 24,593,000 | 25,766,000 | 24,566,000 | 25,438,000 | 1,725,000 | 1,533,000 | 1,470,000 | 2,437,000 | 6,638,000 | 11,184,000 | 18,470,000 | 20,846,000 | 18,097,000 | 19,958,000 | 21,318,000 |
| total liabilities | 1,336,727,000 | 1,524,702,000 | 1,352,979,000 | 1,275,913,000 | 1,237,042,000 | 1,414,443,000 | 1,434,180,000 | 1,397,916,000 | 1,380,783,000 | 1,297,091,000 | 957,876,000 | 903,044,000 | 690,824,000 | 727,940,000 | 725,825,000 | 646,041,000 | 679,177,000 | 688,286,000 | 750,585,000 | 737,044,000 | 623,270,000 | 603,682,000 | 568,968,000 | 589,553,000 | 505,500,000 | 479,248,000 | 532,925,000 | 274,103,000 | 270,239,000 | 251,396,000 | 266,391,000 | 243,251,000 | 243,903,000 | 257,706,000 | 287,725,000 | 91,423,000 | 84,657,000 | 80,935,000 |
| commitments and contingencies | ||||||||||||||||||||||||||||||||||||||
| mezzanine equity | ||||||||||||||||||||||||||||||||||||||
| preferred class a common stock - 0.01 par value; 50,000,000 shares authorized; 175,000 issued, respectively | 228,800,000 | 193,228,000 | 190,173,000 | 187,166,000 | 184,206,000 | 181,294,000 | ||||||||||||||||||||||||||||||||
| shareholders' equity | ||||||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 117,472,681 and 116,575,773 shares issued, respectively | 1,175,000 | |||||||||||||||||||||||||||||||||||||
| additional paid-in-capital | 1,782,992,000 | 1,802,634,000 | 1,803,786,000 | 1,818,024,000 | 1,810,054,000 | 1,805,679,000 | 1,808,121,000 | 1,774,784,000 | 1,768,999,000 | 1,486,857,000 | 1,472,098,000 | 1,231,005,000 | 1,224,250,000 | 1,340,989,000 | 1,249,228,000 | 1,242,900,000 | 1,236,847,000 | 1,229,320,000 | 1,224,956,000 | 1,183,605,000 | 1,180,288,000 | 1,173,708,000 | 1,093,174,000 | 961,472,000 | 953,322,000 | 924,153,000 | 919,962,000 | 747,385,000 | 621,187,000 | 555,250,000 | 397,603,000 | 361,895,000 | 342,063,000 | |||||
| accumulated other comprehensive loss | -1,707,000 | -1,729,000 | -1,753,000 | -1,367,000 | -1,355,000 | -1,308,000 | -1,257,000 | -1,114,000 | -1,122,000 | -1,178,000 | -1,044,000 | -782,000 | -494,000 | |||||||||||||||||||||||||
| retained earnings | -865,332,000 | -845,435,000 | -780,817,000 | -758,015,000 | -734,878,000 | -736,474,000 | -719,194,000 | -606,154,000 | -594,805,000 | -596,928,000 | -592,340,000 | -626,779,000 | -621,132,000 | -608,092,000 | -598,985,000 | -589,178,000 | -574,553,000 | -537,205,000 | -333,684,000 | -251,962,000 | -53,866,000 | -28,345,000 | 3,270,000 | 50,009,000 | 66,696,000 | 79,125,000 | 89,041,000 | 85,952,000 | 99,111,000 | 111,699,000 | 128,605,000 | 146,617,000 | 164,024,000 | 175,232,000 | 306,688,000 | |||
| treasury stock | -21,123,000 | -21,123,000 | -21,123,000 | -21,123,000 | -21,123,000 | -21,123,000 | -21,123,000 | -21,123,000 | -21,123,000 | -21,123,000 | -21,123,000 | -21,123,000 | -21,123,000 | -21,123,000 | -21,123,000 | -21,123,000 | -21,123,000 | |||||||||||||||||||||
| total shareholders’ equity | 896,005,000 | |||||||||||||||||||||||||||||||||||||
| total liabilities, mezzanine equity and shareholders’ equity | 2,461,532,000 | |||||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 117,397,804 and 116,575,773 shares issued, respectively | 1,174,000 | |||||||||||||||||||||||||||||||||||||
| restricted cash and restricted investments | 59,295,000 | 16,343,000 | 20,053,000 | 51,594,000 | 13,768,000 | 23,208,000 | 47,477,000 | 21,932,000 | 14,492,000 | 25,057,000 | 74,377,000 | 39,647,000 | 75,685,000 | 16,509,000 | 17,742,000 | 53,479,000 | 14,437,000 | 21,985,000 | 46,894,000 | 54,409,000 | 20,080,000 | 101,475,000 | 38,619,000 | 50,920,000 | 154,718,000 | 42,328,000 | 53,660,000 | 33,364,000 | 62,398,000 | 5,070,000 | 10,258,000 | 23,254,000 | 34,416,000 | |||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 116,575,773 and 115,424,833 shares issued, respectively | 1,166,000 | |||||||||||||||||||||||||||||||||||||
| total shareholders' equity | 1,001,259,000 | 1,067,701,000 | 859,417,000 | 856,138,000 | 613,088,000 | 611,209,000 | 693,633,000 | 607,484,000 | 614,190,000 | 617,298,000 | 619,600,000 | 654,745,000 | 646,864,000 | 847,072,000 | 929,047,000 | 1,124,348,000 | 1,146,756,000 | 1,150,126,000 | 1,189,356,000 | 1,048,573,000 | 1,051,381,000 | 1,054,914,000 | 1,046,306,000 | 1,055,779,000 | 894,449,000 | 896,740,000 | ||||||||||||
| total liabilities, mezzanine equity and shareholders' equity | 2,544,411,000 | 2,680,308,000 | ||||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 116,550,263 and 115,424,833 shares issued, respectively | 1,166,000 | |||||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 116,261,854 and 115,424,833 shares issued, respectively | 1,163,000 | |||||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 116,195,270 and 115,424,833 shares issued, respectively | 1,162,000 | |||||||||||||||||||||||||||||||||||||
| investments in equity method investees | 4,895,000 | 4,867,000 | 4,254,000 | 4,112,000 | 4,475,000 | 5,222,000 | 3,831,000 | 3,679,000 | 5,458,000 | |||||||||||||||||||||||||||||
| preferred class a common stock - 0.01 par value; 50,000,000 shares authorized; 175,000 and 0 shares issued, respectively | 178,427,000 | 175,606,000 | 172,829,000 | |||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 115,424,833 and 101,500,558 shares issued, respectively | 1,154,000 | |||||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 114,789,963 and 101,500,558 shares issued, respectively | 1,148,000 | |||||||||||||||||||||||||||||||||||||
| tax receivable agreement liability | 112,134,000 | 112,134,000 | 45,950,000 | 42,870,000 | ||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 113,082,503 and 101,500,558 shares issued, respectively | 1,131,000 | |||||||||||||||||||||||||||||||||||||
| preferred class a common stock - 0.01 par value; 50,000,000 shares authorized; 175,000 shares issued | 170,625,000 | |||||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 112,552,160 and 101,500,558 shares issued, respectively | 1,125,000 | |||||||||||||||||||||||||||||||||||||
| liabilities and shareholders’ equity | ||||||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 101,500,558 and 90,758,318 shares issued, respectively | 1,015,000 | |||||||||||||||||||||||||||||||||||||
| total liabilities and shareholders' equity | 1,817,293,000 | 1,759,182,000 | 1,303,912,000 | 1,339,149,000 | 1,419,458,000 | 1,253,525,000 | 1,293,367,000 | 1,305,584,000 | 1,370,185,000 | 1,391,789,000 | 1,270,134,000 | 1,450,754,000 | 1,498,015,000 | 1,713,901,000 | 1,652,256,000 | 1,629,374,000 | 1,722,281,000 | 1,322,676,000 | 1,321,620,000 | 1,306,310,000 | 1,312,697,000 | 1,299,030,000 | 1,138,352,000 | 1,154,446,000 | 851,280,000 | 852,801,000 | ||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 101,159,072 and 90,758,318 shares issued, respectively | 1,012,000 | |||||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 91,657,480 and 90,758,318 shares issued, respectively | 916,000 | |||||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 91,587,896 and 90,758,318 shares issued, respectively | 916,000 | |||||||||||||||||||||||||||||||||||||
| current assets of discontinued operations | ||||||||||||||||||||||||||||||||||||||
| non-current assets of discontinued operations | ||||||||||||||||||||||||||||||||||||||
| short-term debt, net of discount | 26,704,000 | 26,655,000 | 26,606,000 | 26,557,000 | ||||||||||||||||||||||||||||||||||
| current liabilities of discontinued operations | ||||||||||||||||||||||||||||||||||||||
| long-term debt, net of discount | 215,676,000 | 211,063,000 | 206,550,000 | 202,132,000 | 263,343,000 | 285,213,000 | 299,746,000 | 296,676,000 | 293,667,000 | 227,996,000 | 225,642,000 | 223,320,000 | 221,041,000 | 122,082,000 | 121,853,000 | 121,623,000 | 121,394,000 | 121,164,000 | 120,935,000 | 120,706,000 | 120,283,000 | |||||||||||||||||
| non-current liabilities from discontinued operations | ||||||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 90,758,318 and 85,894,450 shares issued, respectively | 908,000 | |||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive income | -362,000 | -363,000 | -367,000 | -309,000 | -278,000 | -320,000 | -391,000 | -387,000 | -234,000 | -215,000 | -147,000 | -158,000 | -182,000 | -264,000 | -148,000 | |||||||||||||||||||||||
| investments in and advances to equity method investees | 5,004,000 | 9,788,000 | 4,909,000 | 6,498,000 | 7,473,000 | 100,216,000 | 75,074,000 | 122,618,000 | 55,528,000 | 59,167,000 | 6,188,000 | 6,276,000 | 5,672,000 | |||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 87,456,228 and 85,894,450 shares issued, respectively | 874,000 | |||||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 87,195,128 and 85,894,450 shares issued, respectively | 872,000 | |||||||||||||||||||||||||||||||||||||
| prepaid expenses and other noncurrent assets, net of allowances | 6,218,000 | 5,832,000 | 7,450,000 | 6,437,000 | 5,801,000 | |||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 86,778,341 and 85,894,450 shares issued, respectively | 868,000 | |||||||||||||||||||||||||||||||||||||
| investments, at amortized cost | 3,858,000 | 4,677,000 | 834,000 | 1,413,000 | 1,807,000 | 3,815,000 | 4,048,000 | 2,046,000 | 10,010,000 | 24,027,000 | 33,684,000 | 44,341,000 | 49,693,000 | 27,577,000 | 9,445,000 | |||||||||||||||||||||||
| contract assets | 329,000 | 671,000 | 2,346,000 | 1,752,000 | 1,751,000 | 1,365,000 | 1,187,000 | 1,282,000 | 2,102,000 | 3,705,000 | 3,008,000 | 4,092,000 | ||||||||||||||||||||||||||
| customer advance for regulatory capital requirements, net of allowances | 39,955,000 | 39,955,000 | ||||||||||||||||||||||||||||||||||||
| reserve for claims and performance-based arrangements | 188,685,000 | 208,313,000 | 94,409,000 | 89,010,000 | 61,150,000 | 33,052,000 | 30,019,000 | |||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 85,894,450 and 84,588,629 shares issued, respectively | 859,000 | |||||||||||||||||||||||||||||||||||||
| total shareholders' equity attributable to evolent health, inc. | 619,600,000 | 629,818,000 | 646,864,000 | |||||||||||||||||||||||||||||||||||
| non-controlling interests | 24,927,000 | 6,689,000 | 15,888,000 | 16,078,000 | 50,100,000 | 45,532,000 | 10,008,000 | 10,148,000 | 11,772,000 | 35,427,000 | 35,932,000 | 34,680,000 | 146,269,000 | 209,588,000 | 197,629,000 | 230,416,000 | 285,238,000 | |||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 85,756,991 and 84,588,629 shares issued, respectively | 858,000 | |||||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 85,456,905 and 84,588,629 shares issued and outstanding, respectively | 855,000 | |||||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 85,449,747 and 84,588,629 shares issued and outstanding, respectively | 855,000 | |||||||||||||||||||||||||||||||||||||
| total shareholders' equity (deficit) attributable to evolent health, inc. | 847,072,000 | 922,358,000 | 1,108,460,000 | 1,130,678,000 | 1,100,026,000 | 1,143,824,000 | 1,038,565,000 | 1,041,233,000 | 1,043,142,000 | 1,010,879,000 | 1,019,847,000 | 859,769,000 | 750,471,000 | 702,526,000 | 562,228,000 | 537,728,000 | 649,341,000 | |||||||||||||||||||||
| customer advance for regulatory capital requirements | 40,000,000 | 40,000,000 | 40,000,000 | |||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 84,588,629 and 79,172,118 shares issued and outstanding, respectively | 846,000 | |||||||||||||||||||||||||||||||||||||
| class b common stock - 0.01 par value; 100,000,000 shares authorized; 0 and 3,190,301 shares issued and outstanding, respectively | ||||||||||||||||||||||||||||||||||||||
| operating lease liabilities - current | 5,390,000 | 4,649,000 | 3,439,000 | |||||||||||||||||||||||||||||||||||
| reserves for claims and performance-based arrangements | 43,073,000 | |||||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized as of september 30, 2019 and december 31, 2018; | ||||||||||||||||||||||||||||||||||||||
| 83,825,595 and 79,172,118 shares issued and outstanding as of september 30, 2019 and december 31, 2018, respectively | 838,000 | |||||||||||||||||||||||||||||||||||||
| class b common stock - 0.01 par value; 100,000,000 shares authorized as of september 30, 2019 and december 31, 2018; | ||||||||||||||||||||||||||||||||||||||
| 706,273 and 3,190,301 shares issued and outstanding as of september 30, 2019 and december 31, 2018, respectively | 7,000 | |||||||||||||||||||||||||||||||||||||
| additional paid-in capital | 1,161,696,000 | 1,158,325,000 | 1,096,089,000 | 971,341,000 | ||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized as of june 30, 2019 and december 31, 2018; | ||||||||||||||||||||||||||||||||||||||
| 83,814,852 and 79,172,118 shares issued and outstanding as of june 30, 2019 and december 31, 2018, respectively | 838,000 | |||||||||||||||||||||||||||||||||||||
| class b common stock - 0.01 par value; 100,000,000 shares authorized as of june 30, 2019 and december 31, 2018; | ||||||||||||||||||||||||||||||||||||||
| 706,273 and 3,190,301 shares issued and outstanding as of june 30, 2019 and december 31, 2018, respectively | 7,000 | |||||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized as of march 31, 2019 and december 31, 2018; | ||||||||||||||||||||||||||||||||||||||
| 79,428,728 and 79,172,118 shares issued and outstanding as of march 31, 2019 and december 31, 2018, respectively | 794,000 | |||||||||||||||||||||||||||||||||||||
| class b common stock - 0.01 par value; 100,000,000 shares authorized as of march 31, 2019 and december 31, 2018; | ||||||||||||||||||||||||||||||||||||||
| 3,190,301 shares issued and outstanding as of march 31, 2019 and december 31, 2018 | 31,000 | |||||||||||||||||||||||||||||||||||||
| notes receivable | 6,000,000 | 12,000,000 | 16,000,000 | 20,000,000 | ||||||||||||||||||||||||||||||||||
| prepaid expenses and other noncurrent assets (amounts related to affiliates: 2018 - 2,500; 2017 - 0 | 15,028,000 | |||||||||||||||||||||||||||||||||||||
| claims reserves | 27,595,000 | 10,338,000 | 9,466,000 | 6,699,000 | ||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized as of december 31, 2018 and 2017; | ||||||||||||||||||||||||||||||||||||||
| 79,172,118 and 74,723,597 shares issued and outstanding as of december 31, 2018 and 2017, respectively | 792,000 | |||||||||||||||||||||||||||||||||||||
| class b common stock - 0.01 par value; 100,000,000 shares authorized as of december 31, 2018 and 2017; | ||||||||||||||||||||||||||||||||||||||
| 3,190,301 and 2,653,544 shares issued and outstanding as of december 31, 2018 and 2017, respectively | 31,000 | |||||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 78,392,052 and 74,723,597 | ||||||||||||||||||||||||||||||||||||||
| shares issued and outstanding as of september 30, 2018, and december 31, 2017, respectively | 784,000 | |||||||||||||||||||||||||||||||||||||
| class b common stock - 0.01 par value; 100,000,000 shares authorized; 765,646 and 2,653,544 | ||||||||||||||||||||||||||||||||||||||
| investments in and advances to affiliates | 4,246,000 | 5,521,000 | 1,531,000 | 712,000 | 1,081,000 | 1,636,000 | 2,159,000 | 2,538,000 | 2,986,000 | |||||||||||||||||||||||||||||
| prepaid expenses and other non-current assets | 11,838,000 | 10,045,000 | 9,328,000 | 9,364,000 | 9,483,000 | 9,782,000 | 10,043,000 | 12,118,000 | 9,859,000 | |||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 77,577,615 and 74,723,597 | ||||||||||||||||||||||||||||||||||||||
| shares issued and outstanding as of june 30, 2018, and december 31, 2017, respectively | 776,000 | |||||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 76,979,298 and 74,723,597 | ||||||||||||||||||||||||||||||||||||||
| shares issued and outstanding as of march 31, 2018, and december 31, 2017, respectively | 770,000 | |||||||||||||||||||||||||||||||||||||
| class b common stock - 0.01 par value; 100,000,000 shares authorized; 880,646 and 2,653,544 | ||||||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized as of december 31, 2017 and 2016; | ||||||||||||||||||||||||||||||||||||||
| 74,723,597 and 52,586,899 shares issued and outstanding as of december 31, 2017 and 2016, respectively | 747,000 | |||||||||||||||||||||||||||||||||||||
| class b common stock - 0.01 par value; 100,000,000 shares authorized as of december 31, 2017 and 2016; | ||||||||||||||||||||||||||||||||||||||
| 2,653,544 and 15,346,981 shares issued and outstanding as of december 31, 2017 and 2016, respectively | 27,000 | |||||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 74,657,870 and 52,586,899 | ||||||||||||||||||||||||||||||||||||||
| shares issued and outstanding as of september 30, 2017, and december 31, 2016, respectively | 747,000 | |||||||||||||||||||||||||||||||||||||
| class b common stock - 0.01 par value; 100,000,000 shares authorized; 2,653,544 and 15,346,981 | ||||||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 65,765,584 and 52,586,899 | ||||||||||||||||||||||||||||||||||||||
| shares issued and outstanding as of june 30, 2017, and december 31, 2016, respectively | 658,000 | |||||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 57,026,226 and 52,586,899 | ||||||||||||||||||||||||||||||||||||||
| shares issued and outstanding as of march 31, 2017, and december 31, 2016, respectively | 570,000 | |||||||||||||||||||||||||||||||||||||
| class b common stock - 0.01 par value; 100,000,000 shares authorized; 10,948,832 and 15,346,981 | ||||||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized as of december 31, 2016 and 2015; | ||||||||||||||||||||||||||||||||||||||
| 52,586,899 and 41,491,498 shares issued and outstanding as of december 31, 2016 and 2015, respectively | 506,000 | |||||||||||||||||||||||||||||||||||||
| class b common stock - 0.01 par value; 100,000,000 shares authorized as of december 31, 2016 and 2015; | ||||||||||||||||||||||||||||||||||||||
| 15,346,981 and 17,524,596 shares issued and outstanding as of december 31, 2016 and 2015, respectively | 153,000 | |||||||||||||||||||||||||||||||||||||
| total equity | 912,114,000 | 759,857,000 | 768,144,000 | 934,579,000 | ||||||||||||||||||||||||||||||||||
| total liabilities, redeemable preferred stock and shareholders' equity | 1,199,839,000 | 1,015,514,000 | ||||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 45,028,807 and 41,491,498 | ||||||||||||||||||||||||||||||||||||||
| shares issued and outstanding as of september 30, 2016, and december 31, 2015, respectively | 448,000 | |||||||||||||||||||||||||||||||||||||
| class b common stock - 0.01 par value; 100,000,000 shares authorized; 15,346,981 and 17,524,596 | ||||||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 shares authorized; 42,669,458 and 41,491,498 | ||||||||||||||||||||||||||||||||||||||
| shares issued and outstanding as of june 30, 2016, and december 31, 2015, respectively | 426,000 | |||||||||||||||||||||||||||||||||||||
| class b common stock - 0.01 par value; 100,000,000 shares authorized; 17,524,596 | ||||||||||||||||||||||||||||||||||||||
| shares issued and outstanding as of june 30, 2016, and december 31, 2015 | 175,000 | |||||||||||||||||||||||||||||||||||||
| equity method investment | ||||||||||||||||||||||||||||||||||||||
| liabilities, redeemable preferred stock and shareholders’ equity | ||||||||||||||||||||||||||||||||||||||
| redeemable preferred stock | ||||||||||||||||||||||||||||||||||||||
| series a redeemable preferred stock - zero and 7,900,000 shares authorized, issued and outstanding as of december 31, 2015 and | ||||||||||||||||||||||||||||||||||||||
| 2014, respectively; liquidation value of zero and 25,018 as of december 31, 2015 and 2014, respectively | ||||||||||||||||||||||||||||||||||||||
| series b redeemable preferred stock - zero and 6,467,376 shares authorized, issued and outstanding as of december 31, 2015 | ||||||||||||||||||||||||||||||||||||||
| 2014, respectively; liquidation value of zero and 27,359 as of december 31, 2015 and 2014, respectively | ||||||||||||||||||||||||||||||||||||||
| series b-1 redeemable preferred stock - zero and 1,953,124 shares authorized as of december 31, 2015 and 2014, respectively; | ||||||||||||||||||||||||||||||||||||||
| zero and 360,420 shares issued and outstanding as of december 31, 2015 and 2014, respectively; liquidation value of zero | ||||||||||||||||||||||||||||||||||||||
| and 1,478 as of december 31, 2015 and 2014, respectively | ||||||||||||||||||||||||||||||||||||||
| total redeemable preferred stock | ||||||||||||||||||||||||||||||||||||||
| series a preferred stock - 0.001 par value; zero and 7,700,000 shares authorized as of december 31, 2015 and 2014, respectively; | ||||||||||||||||||||||||||||||||||||||
| zero and 7,400,000 shares issued and outstanding as of december 31, 2015 and 2014, respectively; liquidation value of zero | ||||||||||||||||||||||||||||||||||||||
| and 23,200 as of december 31, 2015 and 2014, respectively | ||||||||||||||||||||||||||||||||||||||
| class a common stock - 0.01 par value; 750,000,000 and 33,812,808 shares authorized as of december 31, 2015 and 2014, | ||||||||||||||||||||||||||||||||||||||
| respectively; 41,491,498 and 4,047,484 shares issued and outstanding as of december 31, 2015 and 2014, respectively | 415,000 | |||||||||||||||||||||||||||||||||||||
| class b common stock - 0.01 par value; 100,000,000 and zero shares authorized as of december 31, 2015 and 2014, respectively; | ||||||||||||||||||||||||||||||||||||||
| 17,524,596 and zero shares issued and outstanding as of december 31, 2015 and 2014, respectively | 175,000 |
We provide you with 20 years of balance sheets for Evolent Health stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Evolent Health. Explore the full financial landscape of Evolent Health stock with our expertly curated balance sheets.
The information provided in this report about Evolent Health stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.